Biomedical devices with antimicrobial coatings

Details Biomedical devices with antimicrobial coatings Biomedical devices with antimicrobial coatings

1998-10-02

2003-07-15

McKane, Elizabeth (Department: 1744)

Chemical apparatus and process disinfecting, deodorizing, preser

Process disinfecting, preserving, deodorizing, or sterilizing

Using disinfecting or sterilizing substance

C424S411000, C424S429000, C514S002600, C514S839000

Reexamination Certificate

active

06592814

ABSTRACT:

FIELD OF THE INVENTION
This invention relates to coated devices. In particular, the invention provides biomedical devices on the surfaces of which antimicrobial protein coatings are formed.
BACKGROUND OF THE INVENTION
Devices for use in and on the human body are well known. The chemical composition of the surfaces of such devices plays a pivotal role in dictating the overall efficacy of the devices. Additionally, it is known that providing such devices with an antimicrobial surface is advantageous.
A wide variety of bactericidal and bacteriostatic coatings have been developed. For example, cationic antibiotics, such as polymyxin, vancomycin, and tetracycline have been used as coatings for contact lenses. Further, metal chelating agents, substituted and unsubstituted polyhydric phenols, aminophenols, alcohols, acid and amine derivatives, and quarternary ammonium have been used as antimicrobial agents for contact lenses.
However, the use of these known antimicrobial coatings has disadvantages. With the use of antibiotic coatings, microorganisms resistant to the antibiotics may develop. Chelating agent use fails to address the numbers of bacteria that adhere to the device. Some of the prior art coatings, for example phenol derivatives and cresols, can produce ocular toxicity or allergic reactions. Quarternary ammonium compounds are problematic because of their irritancy. Thus, a need exists for safe and effective antimicrobial coatings that overcomes at least some of these disadvantages.


REFERENCES:
patent: 4184849 (1980-01-01), Cambiaso et al.
patent: 5328954 (1994-07-01), Sarangapani
patent: 5447914 (1995-09-01), Travis et al.
patent: 5472703 (1995-12-01), Vanderlaan et al.
patent: 5486579 (1996-01-01), Lai et al.
patent: 5514732 (1996-05-01), Vanderlaan et al.
patent: 5515117 (1996-05-01), Dziabo et al.
patent: 5549894 (1996-08-01), Hunt
patent: 5607681 (1997-03-01), Galley et al.
patent: 5955316 (1999-09-01), Conneely et al.
patent: 0 050 934 (1982-05-01), None
patent: 0 372 130 (1990-06-01), None
patent: 0 604 369 (1994-06-01), None
patent: 2209523 (1989-05-01), None
patent: 043343103 (1992-11-01), None
patent: WO 92/15198 (1992-09-01), None
Jung, J & Rapp, J, “The Efficacy of Hydrophilic Contact Lens Cleaning Systems in Removing Protein Deposits”, The Contact Lens Association of Ophthalmologists Journal, vol. 19(1), Jan. 1993 (Whole Document).
Williams, T.J. et al. Optometry and Vision Science, vol. 75(4) Apr. 4, 1998; “Interactions of bacteria with contact lenses: The effect of soluble protein and carbohydrate on bacterial adhesion to contact lenses”. p 266-271. (Whole document).
Baguet, J. et al. Biomaterials, vol. 16(1), 1995: “Characterisation of lacrymal comonent accumulation on worn soft contact lens surface by atomic force microscropy”. p 3-9 (Whole Document).
Leahy, C.D. et al. Optometry & Vision Science, vol. 67(7), 1990: “Initial in vivo tear protein deposition on individual hydrogel contact lenses”. p 504-511. (Whole document).
Miller, M.J. et al. Journal of Clinical Microbiology, vol. 26(3), Mar. 1988: “Effects of protein, mucin, and human tears on dherence of Pseudomonas aeruginosa to hydrophillic contact lenses”. p 513-517. (Whole document).
Gadmunsson, O.G. et al. Arch. Ophthalmology, vol. 103, Feb. 1985: Identification of proteins in contact lens surface deposits by immunofluorescence microscopy. p 196-197. (Whole document).
Chemical Abstracts, vol. 102, No. 16, issued Apr. 22, 1985 Columbia, Ohio, USA, Ishil, Yoshimoto; Iwata, Shuzo, “Studies on the interaction between contact lens and tear fluid (VII). Phenomenon of human tear Iysozyme and lactoferrin adsorption onto contact lens material”, p. 370, column 2, the abstract No. 137743p, Nippon Kontakuto Renzu Gakkai Kaishi. 1984, 26(3), 225-9 (Japan) Abstract.
Kijlstra, A, “The Role of Lactoferrin in the Nonspecific Immune Response on the Ocular Surface”, Reg. Immunol, 3(4) :Abstract, 1990-91.
Bellamy, W. et al., “Antibacterial Spectrum of Lactoferricin B, a Potent Bactericidal Peptide Derived from the N-terminal Region of Bovine Lactofferin”, J. Appl. Bacteriol, 73(6):Abstract, Dec. 1992.
Tomita, M. et al., “Potent Antibacterial Peptides Generated by Pepsin Digestion of Bovine Lactoferrin”, J. Dairy Sci., 74 (12) :Abstract, Dec. 1991.
Yamauchi, K. et al., “Antibacterial Activity of Lactoferrin and a Pepsin-Derived Lactoferrin Peptide Fragment”, Infect Immun, 61(2) :Abstract Feb. 1993.

Affiliated with

Also associated with

Rating

Biomedical devices with antimicrobial coatings does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biomedical devices with antimicrobial coatings, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomedical devices with antimicrobial coatings will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3108249